Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Ticagrelor Market Growth Potential: How Will Market Size Change Through 2030?
The ticagrelor market has seen notable expansion in recent years, with its size projected to increase from $1.93 billion in 2025 to $2.08 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.6%. This past period of growth was driven by factors such as the restricted range of available antiplatelet therapies, a rising incidence of cardiovascular conditions, the broadening of hospital pharmacy networks, a growing number of clinical trials focused on cardiovascular medications, and heightened public awareness of the dangers posed by heart attacks and strokes.
Projections indicate that the ticagrelor market will experience robust expansion in the coming years, reaching a valuation of $2.75 billion by 2030 with a compound annual growth rate (CAGR) of 7.3%. This anticipated growth in the forecast period stems from factors including the introduction of extended-release ticagrelor tablets, growing distribution channels through retail pharmacies and online platforms, a rising focus on personalized cardiovascular care, heightened government efforts to prevent heart disease, and the integration of such treatments with digital health monitoring systems. Key trends driving this trajectory encompass the increased application of ticagrelor in managing acute coronary syndrome, a shift in preference toward oral antiplatelet therapies over injectable alternatives, the expansion of both hospital and ambulatory cardiology services, greater awareness around preventing strokes and myocardial infarctions, and the development of novel extended-release ticagrelor formulations.
Download A Free Sample Report For Comprehensive Market Insights:
Ticagrelor Market Demand Drivers Creating New Revenue Opportunities
The rising incidence of cardiovascular diseases is anticipated to boost the ticagrelor market in the coming period. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. This growing prevalence is largely driven by unhealthy dietary habits, where high consumption of saturated fats, trans fats, added sugars, and sodium leads to elevated blood pressure, obesity, and increased cholesterol levels—key contributors to heart conditions. Ticagrelor addresses these diseases by inhibiting platelet aggregation, thereby lowering the risk of blood clot formation. It enhances patient outcomes by reducing the likelihood of heart attacks and strokes, particularly among those at elevated risk. As reported by the American Heart Association in January 2024, the age-adjusted cardiovascular disease death rate in the United States rose to 233.3 per 100,000 in 2024, a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the escalating prevalence of cardiovascular diseases is fueling the expansion of the ticagrelor market.
Ticagrelor Market Segment Outlook: Which Categories Are Expanding The Fastest?
The ticagrelor market covered in this report is segmented –
1) By Type: 90 mg Tablet, 60 mg Tablet
2) By Drug Class: Antiplatelet Agents, Antithrombotic Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Acute Coronary Syndrome, Myocardial Infarction, Stroke Prevention, Other Applications
5) By End User: Hospitals And Clinics, Ambulatory Centers, Other End Users
Ticagrelor Market Trends Driving Strategic Industry Expansion
Key players in the ticagrelor market are actively pursuing regulatory approvals to broaden product indications, improve market reach, and enhance their competitive edge. Such approvals represent official authorization from government bodies to commercialize a product, confirming its compliance with safety, effectiveness, and quality benchmarks. A case in point is May 2025, when Alembic Pharmaceuticals Ltd., a pharmaceutical firm based in India, secured an abbreviated new drug application (ANDA) from the US Food & Drug Administration (USFDA) for its generic ticagrelor tablets in 90 mg strength, along with tentative approval for the 60 mg version. These tablets are designed to lower the likelihood of cardiovascular incidents by inhibiting platelet aggregation, thus preventing blood clot formation.
Ticagrelor Market Key Companies And Competitive Benchmarking
Major companies operating in the ticagrelor market are AstraZeneca PLC, Merck KGaA, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Cadila Pharmaceuticals Limited, Alkem Laboratories, Alembic Pharmaceuticals Limited, CCL Pharmaceuticals, Neuland Laboratories, Jiangxi Synergy Pharmaceutical Co. Ltd., Leeford Healthcare Limited, Scimplify, JAMP Pharma Corporation, Actoverco Pharmaceutical Company, CTX Lifesciences Private Limited, DM Pharma, Hema Pharmaceuticals Pvt. Ltd., Chia-Tai Tianqing Pharmaceutical Group Co. Ltd., Biophar Lifesciences Pvt. Ltd., PhaseBio Pharmaceuticals Inc.
Access The Complete Ticagrelor Market Report:
Ticagrelor Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the ticagrelor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ticagrelor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model